TY - JOUR
T1 - Hormone-replacement therapy – breast versus heart versus bone
AU - Davidson, Nancy E.
PY - 1995/6/15
Y1 - 1995/6/15
N2 - Thanks to many public health advances, in the developed countries the average woman will be postmenopausal for about one third of her life. As a consequence, she and her physician will ultimately need to make a decision about postmenopausal estrogen-replacement therapy. This treatment has been used for several decades, but there is a surprising lack of consensus about when and how to use it. The initial goal of estrogen-replacement therapy was to alleviate menopausal symptoms. More recently, the possibility has emerged that estrogen can reduce morbidity and mortality from ischemic heart disease and osteoporosis. However, women and their physicians must.
AB - Thanks to many public health advances, in the developed countries the average woman will be postmenopausal for about one third of her life. As a consequence, she and her physician will ultimately need to make a decision about postmenopausal estrogen-replacement therapy. This treatment has been used for several decades, but there is a surprising lack of consensus about when and how to use it. The initial goal of estrogen-replacement therapy was to alleviate menopausal symptoms. More recently, the possibility has emerged that estrogen can reduce morbidity and mortality from ischemic heart disease and osteoporosis. However, women and their physicians must.
UR - http://www.scopus.com/inward/record.url?scp=0029071008&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029071008&partnerID=8YFLogxK
U2 - 10.1056/NEJM199506153322409
DO - 10.1056/NEJM199506153322409
M3 - Editorial
C2 - 7753144
AN - SCOPUS:0029071008
SN - 0028-4793
VL - 332
SP - 1638
EP - 1639
JO - New England Journal of Medicine
JF - New England Journal of Medicine
IS - 24
ER -